ASEP Medical Holdings Inc. (ASEP.CN)
Canadian Sec · CAD · Healthcare · Biotechnology
CA$0.10 (-23.08%) as of
Key statistics
- Market cap
- 2.49M
- EPS (TTM)
- -0.3700
- Dividend yield
- 0.00%
- 52-week range
- 0.0550 – 0.5000
- Beta
- -1.35
- Revenue (TTM)
- 336.77k
- Profit margin
- 0.00%
- Volume
- 4.92k
About ASEP Medical Holdings Inc.
ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics. It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, antibiotic synergy, and immune modulating; diagnostic kits for predicting the onset of severe sepsis; and medical devices with anti-microbial and antifouling coating. The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to ASEP Medical Holdings Inc. in November 2021. ASEP Medical Holdings Inc. was incorporated in 2021 and is headquartered in Victoria, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Victoria, BC, Canada
- Employees
- 3
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.